Medical Stocks Worth Watching - April 24th

Key Points

• MarketBeat's screener flags seven medical stocks with the highest recent dollar trading volume: Eli Lilly, UnitedHealth Group, HCA Healthcare, Hims & Hers Health, Predictive Oncology, Thermo Fisher Scientific, and Novo Nordisk.
• Eli Lilly and Novo Nordisk stand out for large diabetes and obesity drug franchises (e.g., Mounjaro, Zepbound), and Eli Lilly is making a multibillion-dollar push into AI and neuroscience.
• Predictive Oncology combines machine learning with a ~150,000‑sample tumor biobank to accelerate oncology discovery, while Thermo Fisher, UnitedHealth, and HCA provide exposure to diagnostics, lab services, and healthcare delivery — offering innovation upside but also sector-specific regulatory and reimbursement risks.

Eli Lilly and Company, UnitedHealth Group, HCA Healthcare, Hims & Hers Health, Predictive Oncology, Thermo Fisher Scientific, and Novo Nordisk A/S are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. "Medical stocks" are shares of publicly traded companies whose primary business is in healthcare — including pharmaceuticals, biotechnology, medical devices, diagnostics, hospitals, clinics, and related services or suppliers. For investors, these equities represent ownership in firms exposed to industry-specific drivers such as clinical trial outcomes, regulatory approvals, patent protections, reimbursement policies, and can therefore offer growth potential but also higher volatility and sector-specific risk. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Read Our Latest Research Report on LLY

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read Our Latest Research Report on UNH

HCA Healthcare (HCA)

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read Our Latest Research Report on HCA

Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Read Our Latest Research Report on HIMS

Predictive Oncology (POAI)

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.

Read Our Latest Research Report on POAI

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Read Our Latest Research Report on TMO

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Read Our Latest Research Report on NVO

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.